EGL-003 for Autoimmune Diseases

We are testing a new treatment called EGL-003 to see how safe it is and how the body handles it. The study starts with healthy volunteers and then includes adults with autoimmune diseases.

1-2 yearsSafety phase (I)DermatologyRheumatology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Medical Center Etika Ambulatory For Specialized Outpatient Medical Care OOD
Not applicable
Dolni Chiflik, Bulgaria
Medical Center Medconsult Pleven OOD
Dermatology
Lovech, Bulgaria
Medical Center Medconsult Pleven OOD
Dermatology
Pleven, Bulgaria

Sponsor: Egle Therapeutics
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.